triazoles has been researched along with Torsade de Pointes in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, X; Yu, Z | 1 |
| Bossu, A; van Weperen, VYH; Vos, MA | 1 |
| Beekman, HDM; Belardinelli, L; Bossu, A; de Bakker, JMT; Dunnink, A; Houtman, MJC; Meijborg, VMF; Mollova, N; Rajamani, S; van der Heyden, MAG; Varkevisser, R; Vos, MA | 1 |
| Mason, JW | 1 |
| Atalay, S; Aypar, E; Çiftçi, E; Ileri, T; Ince, E; Kendirli, T; Tutar, E | 1 |
| Cil, H; Elbey, MA; Islamoglu, Y; Onturk, E | 1 |
| Estes, LL; Wilson, JW; Zeuli, JD | 1 |
| Khan, IA; Siddiqui, MA | 1 |
| Alkan, Y; Burhenne, J; Haefeli, WE; Shalit, I; Stein, J; Yaniv, I | 1 |
| Nolin, TD; Owens, RC | 1 |
| Baden, LR; Katz, JT; Koplan, BA; Marty, FM; Philips, JA; Stone, RM | 1 |
| Amedro, P; Blayac, JP; Cociglio, M; Eiden, C; Hillaire-Buys, D; Margueritte, G; Peyrière, H; Tichit, R | 1 |
| Aldridge, A; Duffy, PA; Harada, T; Inokuma, M; Matsunaga, T; Mitsui, T; Shibutani, Y | 1 |
| Aldridge, A; Duffy, PA; Harada, T; Matsunaga, T; Mitsui, T; Murano, H; Shibutani, Y | 1 |
| Harada, T; Hirata, Z; Matsunaga, T; Mitsui, T; Murano, H; Shibutani, Y | 1 |
2 review(s) available for triazoles and Torsade de Pointes
| Article | Year |
|---|---|
Point of View: Electrophysiological Endpoints Differ When Comparing the Mode of Action of Highly Successful Anti-arrhythmic Drugs in the CAVB Dog Model With TdP.
Topics: Action Potentials; Aniline Compounds; Animals; Anti-Arrhythmia Agents; Atrioventricular Block; Chronic Disease; Disease Models, Animal; Dogs; Electrophysiologic Techniques, Cardiac; Endpoint Determination; Flunarizine; Heart Rate; Phenyl Ethers; Pyridines; Time Factors; Torsades de Pointes; Triazoles; Verapamil | 2019 |
Antimicrobial-associated QT interval prolongation: pointes of interest.
Topics: Anti-Infective Agents; Antifungal Agents; Biomarkers; Fluoroquinolones; Humans; Imidazoles; Ketolides; Long QT Syndrome; Macrolides; Torsades de Pointes; Triazoles | 2006 |
13 other study(ies) available for triazoles and Torsade de Pointes
| Article | Year |
|---|---|
Torsade de Pointes/QT Prolongation Associated with Antifungal Triazoles: A Pharmacovigilance Study Based on the U.S. FDA Adverse Event Reporting System（FAERS）.
Topics: Antifungal Agents; Bayes Theorem; DNA-Binding Proteins; Humans; Long QT Syndrome; Pharmacovigilance; Retrospective Studies; Software; Torsades de Pointes; Triazoles | 2022 |
Selective late sodium current inhibitor GS-458967 suppresses Torsades de Pointes by mostly affecting perpetuation but not initiation of the arrhythmia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Dose-Response Relationship, Drug; Myocytes, Cardiac; Phenethylamines; Pyridines; Sulfonamides; Torsades de Pointes; Triazoles | 2018 |
Antimicrobials and QT prolongation.
Topics: Anti-Bacterial Agents; Education, Medical; Humans; Ketolides; Long QT Syndrome; Macrolides; Potassium Channels, Inwardly Rectifying; Practice Patterns, Physicians'; Torsades de Pointes; Triazoles | 2017 |
Voriconazole-induced QT interval prolongation and torsades de pointes.
Topics: Adolescent; Antifungal Agents; Child; Electrocardiography; Endocarditis; Female; Humans; Long QT Syndrome; Male; Pulmonary Aspergillosis; Pyrimidines; Torsades de Pointes; Triazoles; Trichosporonosis; Voriconazole | 2011 |
OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
Topics: Adult; Antifungal Agents; Cardiac Pacing, Artificial; Cardiopulmonary Resuscitation; Electric Countershock; Electrocardiography; Electrolytes; Female; Humans; Long QT Syndrome; Mitral Valve Insufficiency; Nephrotic Syndrome; Pyrimidines; Rheumatic Heart Disease; Torsades de Pointes; Triazoles; Voriconazole | 2012 |
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole | 2013 |
Nefazodone-associated torsade de pointes.
Topics: Antidepressive Agents, Second-Generation; Female; Humans; Middle Aged; Piperazines; Torsades de Pointes; Triazoles | 2004 |
Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
Topics: Adolescent; Antifungal Agents; Bradycardia; Female; Fusarium; Humans; Mycoses; Opportunistic Infections; Pyrimidines; Tachycardia, Ventricular; Torsades de Pointes; Triazoles; Voriconazole | 2004 |
Torsades de pointes associated with voriconazole use.
Topics: Administration, Oral; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Cardiomyopathies; Dermatomycoses; Drug Synergism; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Voriconazole | 2007 |
Inherited long QT syndrome revealed by antifungals drug-drug interaction.
Topics: Acute Disease; Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; Injections, Intravenous; Leukemia, Myeloid; Long QT Syndrome; Mixed Function Oxygenases; Mucormycosis; Pyrimidines; Torsades de Pointes; Triazoles; Voriconazole | 2007 |
QT prolongation and torsades de pointes induced by an antifungal agent, D0870, in conscious dogs.
Topics: Animals; Antifungal Agents; Dogs; Electrocardiography; Female; Male; Torsades de Pointes; Triazoles | 1999 |
Influences of catecholamines on the sudden death induced in dogs by an antifungal agent, D0870.
Topics: Action Potentials; Animals; Antifungal Agents; Catecholamines; Death, Sudden, Cardiac; Dogs; Electrocardiography; Epinephrine; Heart Ventricles; Isoproterenol; Torsades de Pointes; Triazoles | 2000 |
D0870, an antifungal agent, induces reverse use-dependent QT prolongation in dogs.
Topics: Action Potentials; Animals; Antifungal Agents; Dogs; Electric Stimulation; Electrocardiography, Ambulatory; Female; Male; Purkinje Fibers; Torsades de Pointes; Triazoles | 2000 |